| Literature DB >> 30805210 |
Seda Karaca Adıyeke1, Gamze Ture1, Fatma Mutlubaş2, Hasan Aytoğan1, Onur Vural1, Neslisah Kutlu Uzakgider1, Gulsah Talay Dayangaç1, Ekrem Talay1.
Abstract
OBJECTIVE: To evaluate optical coherence tomography (OCT) findings of pediatric Alport syndrome (AS) patients with no retinal pathology on fundus examination.Entities:
Year: 2019 PMID: 30805210 PMCID: PMC6360616 DOI: 10.1155/2019/6741930
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.909
Figure 1EDI-OCT scan of a 20-year-old male patient. Temporal foveal thinning is seen in right eye (a) and left eye (b) of the patient.
Macular thickness values for each group at the 1 mm diameter circle centered on the fovea and the parafovea 1–3 mm diameter circle in four quadrants.
| Alport syndrome group ( | Control group ( |
| |
|---|---|---|---|
| TIM | 289.40 ± 21.80 | 297.19 ± 26.44 | 0.013 |
| SIM | 291.04 ± 23.30 | 295.18 ± 33.93 | 0.067 |
| NIM | 293.07 ± 21.08 | 297.46 ± 21.47 | 0.07 |
| IIM | 288.83 ± 22.80 | 290.14 ± 20.78 | 0.130 |
| CST | 238.46 ± 30.1 | 241.68 ± 31.2 | 0.562 |
TIM: temporal inner macula, SIM: superior inner macula, NIM: nasal inner macula, IIM: inferior inner macula, and CST: central subfield thickness.. Statistically significant p value.
Figure 2Very small cyst-like occurrences are observed in the outer nuclear layer of a 15-year-old case.
Figure 3Temporal and horizontal OCT scan of a 16-year-old patient. Subfoveal vitelliform lesion is observed in horizontal (a) and vertical scans (b).
Demographic and clinical findings in patients with Alport syndrome.
| No | Age | Sex | Genetic mutation | Clinical and OCT findings | Sph equ RE | Sph equ LE |
|---|---|---|---|---|---|---|
| 1 | 17 | M | COL4A4 | Unilateral vitelliform lesion | +0.75 | −0.50 |
| 2 | 18 | F | COL4A4 | None | −0.25 | 0.00 |
| 3 | 14 | F | COL4A4 | None | +0.25 | +0.25 |
| 4 | 11 | M | COL4A3 | None | +0.50 | +0.375 |
| 5 | 18 | M | COL4A5 | Temporal macula thinning | −0.75 | −1.00 |
| 6 | 16 | M | COL4A5 | Temporal macula thinning | +0.25 | −0.75 |
| 7 | 15 | F | COL4A4 | None | +0.50 | +1.00 |
| 8 | 18 | M | COL4A5 | None | −0.25 | 0.00 |
| 9 | 9 | M | COL4A5 | None | −0.375 | −0.50 |
| 10 | 12 | F | COL4A4 | None | +0.25 | +0.125 |
| 11 | 15 | M | COL4A4 | None | −0.50 | −0.25 |
| 12 | 12 | F | COL4A4 | None | +0.75 | +0.75 |
| 13 | 17 | F | COL4A3 | None | 0 | −0.375 |
| 14 | 13 | M | COL4A4 | None | +0.875 | +0.625 |
| 15 | 13 | F | COL4A4 | None | +0.25 | +0.25 |
| 16 | 12 | F | COL4A4 | None | +0.25 | 0 |
| 17 | 15 | F | COL4A4 | None | +1.25 | +1.00 |
| 18 | 14 | F | COL4A3 | None | +0.50 | +0.25 |
| 19 | 16 | F | COL4A4 | None | +0.125 | +0.375 |
| 20 | 15 | F | COL4A4 | None | +0.75 | +0.50 |
| 21 | 17 | M | COL4A3 | None | −0.375 | −0.875 |
M: male, F: female, Sph equ: spherical equivalent (diopter), RE: right eye, LE: left eye.
RNFL thickness measurements in Alport syndrome and control groups.
| Alport syndrome group ( | Control group ( |
| |
|---|---|---|---|
| RNFLt | 65.92 ± 11.78 | 73.58 ± 8.20 | 0.001 |
| RNFLs | 127.38 ± 19.38 | 144.02 ± 14.57 | 0.001 |
| RNFLsn | 118.52 ± 14.63 | 121.28 ± 22.39 | 0.811 |
| RNFLn | 82.23 ± 9.71 | 80.06 ± 13.18 | 0.270 |
| RNFLin | 114.50 ± 20.58 | 129.6 ± 20.6 | 0.016 |
| RNFLit | 131.09 ± 16.02 | 153.48 ± 18.96 | 0.022 |
| RNFLav | 99.95 ± 7.75 | 106.62 ± 8.42 | 0.001 |